Systematic studies of sulfation and glucuronidation of 12 flavonoids in the mouse liver S9 fraction reveal both unique and shared positional preferences

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 12, 2012, Pages 3223-3233

  Tang, Lan ^a   Zhou, Juan ^a   Yang, Cai Hua ^a   Xia, Bi Jun ^a   Hu, Ming ^a,b   Liu, Zhong Qiu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

flavonoids; glucuronidation; mouse liver S9 fraction; structural preference; sulfation

Indexed keywords

ENZYMATIC REACTION; GLUCURONIDATION; METABOLIC PATHWAYS; MOUSE LIVER; PHASE II; RANK ORDER; REGIOSPECIFIC; STRUCTURAL PREFERENCE; SULFATION; SYSTEMATIC STUDY;

BIOCHEMISTRY; FLAVONOIDS; METABOLISM;

REACTION RATES;

FLAVONE DERIVATIVE; FLAVONOID; GLUCURONIDE; SULFATE;

ANIMAL; ARTICLE; CHEMISTRY; ENZYMOLOGY; KINETICS; LIVER; MALE; METABOLISM; MOUSE;

ANIMALS; FLAVONES; FLAVONOIDS; GLUCURONIDES; KINETICS; LIVER; MALE; MICE; SULFATES;

EID: 84859125713     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf201987k     Document Type: Article

References (35)

1. Thomasset, S. C.; Berry, D. P.; Garcea, G.; Marczylo, T.; Steward, W. P.; Gescher, A. J. Dietary polyphenolic phytochemicals - promising cancer chemopreventive agents in humans? A review of their clinical properties Int. J. Cancer 2007, 120 (3) 451-458
2. Benavente-Garcia, O.; Castillo, J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity J. Agric. Food Chem. 2008, 56 (15) 6185-6205
3. Birt, D. F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: flavonoids and isoflavonoids Pharmacol. Ther. 2001, 90 (2-3) 157-177
4. Moon, J. H.; Nakata, R.; Oshima, S.; Inakuma, T.; Terao, J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279 (2) R461-R467
5. de Vries, J. H.; Hollman, P. C.; Meyboom, S.; Buysman, M. N.; Zock, P. L.; van Staveren, W. A.; Katan, M. B. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake Am. J. Clin. Nutr. 1998, 68 (1) 60-65
6. Zhang, L.; Lin, G.; Zuo, Z. Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein Pharm. Res. 2007, 24 (1) 81-89
7. Day, A. J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M. R.; Williamson, G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin Free Radical Res. 2001, 35 (6) 941-952
8. Shia, C. S.; Tsai, S. Y.; Kuo, S. C.; Hou, Y. C.; Chao, P. D. Metabolism and pharmacokinetics of 3,3′,4′,7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites J. Agric. Food Chem. 2009, 57 (1) 83-89
9. Crespy, V.; Morand, C.; Besson, C.; Manach, C.; Demigne, C.; Remesy, C. Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats J. Nutr. 2001, 131 (8) 2109-2114
10. Azuma, K.; Ippoushi, K.; Ito, H.; Horie, H.; Terao, J. Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats Biosci., Biotechnol., Biochem. 2003, 67 (12) 2548-2555
11. De Santi, C.; Pietrabissa, A.; Spisni, R.; Mosca, F.; Pacifici, G. M. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum Xenobiotica 2000, 30 (6) 609-617
12. Walle, U. K.; Galijatovic, A.; Walle, T. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2 Biochem. Pharmacol. 1999, 58 (3) 431-438
13. Galijatovic, A.; Walle, U. K.; Walle, T. Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells Pharm. Res. 2000, 17 (1) 21-26
14. Hu, M.; Chen, J.; Lin, H. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model J. Pharmacol. Exp. Ther. 2003, 307 (1) 314-321
15. Chen, J.; Lin, H.; Hu, M. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model Cancer Chemother. Pharmacol. 2005, 55 (2) 159-169
16. Joseph, T. B.; Wang, S. W.; Liu, X.; Kulkarni, K. H.; Wang, J.; Xu, H.; Hu, M. Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms Mol. Pharmaceutics 2007, 4 (6) 883-894
17. Wang, S. W.; Kulkarni, K. H.; Tang, L.; Wang, J. R.; Yin, T.; Daidoji, T.; Yokota, H.; Hu, M. Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities J. Pharmacol. Exp. Ther. 2009, 329 (3) 1023-1031
18. Liu, X.; Tam, V. H.; Hu, M. Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA Mol. Pharmaceutics 2007, 4 (6) 873-882
19. Jeong, E. J.; Jia, X.; Hu, M. Disposition of formononetin via enteric recycling: metabolism and excretion in mouse intestinal perfusion and Caco-2 cell models Mol. Pharmaceutics 2005, 2 (4) 319-328
20. Tang, L.; Ye, L.; Singh, R.; Wu, B.; Lv, C.; Zhao, J.; Liu, Z.; Hu, M. Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes. Mol. Pharmaceutics 2010, 7 (3), 664-679.
21. Tang, L.; Singh, R.; Liu, Z.; Hu, M. Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones Mol. Pharmaceutics 2009, 6 (5) 1466-1482
22. Okita, J. R.; Castle, P. J.; Okita, R. T. Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate J. Biochem. Toxicol. 1993, 8 (3) 135-144
23. Chen, J.; Halls, S. C.; Alfaro, J. F.; Zhou, Z.; Hu, M. Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes Pharm. Res. 2004, 21 (11) 2095-2104
24. Zhou, Q.; Zheng, Z.; Xia, B.; Tang, L.; Lv, C.; Liu, W.; Liu, Z.; Hu, M. Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes Pharm. Res. 2010, 27 (8) 1568-1583
25. Tang, L.; Ye, L.; Singh, R.; Wu, B.; Lv, C.; Zhao, J.; Liu, Z.; Hu, M. Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes Mol. Pharmaceutics 2010, 7 (3) 664-679
26. Jeong, E. J.; Lin, H.; Hu, M. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model J. Pharmacol. Exp. Ther. 2004, 310 (1) 376-385
27. Busby, M. G.; Jeffcoat, A. R.; Bloedon, L. T.; Koch, M. A.; Black, T.; Dix, K. J.; Heizer, W. D.; Thomas, B. F.; Hill, J. M.; Crowell, J. A.; Zeisel, S. H. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men Am. J. Clin. Nutr. 2002, 75 (1) 126-136
28. Wang, S. W.; Chen, J.; Jia, X.; Tam, V. H.; Hu, M. Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties Drug Metab. Dispos. 2006, 34 (11) 1837-1848
29. Liu, Y.; Hu, M. Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perused rat intestinal model Drug Metab. Dispos. 2002, 30 (4) 370-377
30. Gibson, D. T.; Hensley, M.; Yoshioka, H.; Mabry, T. J. Formation of (+)- cis -2,3-dihydroxy-1-methylcyclohexa-4,6-diene from toluene by Pseudomonas putida Biochemistry 1970, 9 (7) 1626-1630
31. max) generated from an online diode array detector. J. Agric. Food Chem. 2010, 58 (17), 9384-9395.
32. Itaaho, K.; Alakurtti, S.; Yli-Kauhaluoma, J.; Taskinen, J.; Coughtrie, M. W.; Kostiainen, R. Regioselective sulfonation of dopamine by SULT1A3 in vitro provides a molecular explanation for the preponderance of dopamine-3-O-sulfate in human blood circulation Biochem. Pharmacol. 2007, 74 (3) 504-510
33. Wu, B.; Morrow, J. K.; Singh, R.; Zhang, S.; Hu, M. Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model J. Pharmacol. Exp. Ther. 2011, 336 (2) 403-413
34. de Pascual-Teresa, S.; Johnston, K. L.; DuPont, M. S.; O'Leary, K. A.; Needs, P. W.; Morgan, L. M.; Clifford, M. N.; Bao, Y.; Williamson, G. Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo J. Nutr. 2004, 134 (3) 552-557
35. Vietri, M.; Pietrabissa, A.; Spisni, R.; Mosca, F.; Pacifici, G. M. 7-OH-flavone is sulfated in the human liver and duodenum, whereas 5-OH-flavone and 3-OH-flavone are potent inhibitors of SULT1A1 activity and 7-OH-flavone sulfation rate Xenobiotica 2002, 32 (7) 563-571